Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
PaxMedica, Inc. ( (PXMD) ) has shared an update.
On January 31, 2025, PaxMedica, Inc. announced the immediate resignation of Stephen D. Sheldon from his roles as chief financial officer and chief operational officer. He will continue to support the company through a consulting agreement during the transition of his responsibilities to the CEO, clarifying that his departure was not due to any disagreements with the company or its board. Additionally, Zachary Rome resigned from the board on the same date for personal reasons, also confirming no disputes with the company or board.
More about PaxMedica, Inc.
YTD Price Performance: -55.71%
Average Trading Volume: 45,901
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $11
For an in-depth examination of PXMD stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue